Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...
With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are ...
Edgewise Therapeutics shares tumbled more than 20% Wednesday after the developmental drug company issued the results of its ...
Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered ...
Week99er on MSN3d
Why IRT Clinical Trial Companies Rely on RTSM for Seamless StudiesClinical trials are essential in bringing innovative treatments to the market, but managing them efficiently requires cutting-edge technology. This is where IRT clinical trial companies play a crucial ...
Zacks Investment Research on MSN2d
VEEV Stock Slips Despite New Research Site Clinical Trial SystemVeeva Systems VEEV recently introduced SiteVault, a Clinical Trial Management System (CTMS) designed for research sites. It ...
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...
Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...
A five-year clinical study has revealed that spectacle lenses equipped with highly aspherical lenslets (HAL) can ...
CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...
Novo Nordisk (NVO) stock dropped on Monday despite the drugmaker reporting positive results for its GLP-1 medicine, Rybelsus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback